'Corporate Reputation of Pharma, 2018' Global Report
18 April 2019
The 'Corporate Reputation of Pharma, 2018' Global report is based on the findings of a PatientView November 2018-February 2019 survey exploring the views of 1,500 patient groups worldwide.
The report provides feedback (from the perspective of these patient groups) on the corporate reputation of the pharma industry during 2018, as well as on the performance of 46 pharma companies at 12 key indicators that influence corporate reputation (all of importance to patients and patient groups).
Read the results of the patient perspective, here.